Synthetic peptide within Human CRLF3 aa 304-331 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH). The exact sequence is proprietary.Database link: Q8IUI8
Conjugate
Unconjugated
Applications
Application Notes
WB: 1/100 - 1/500.
Target
Alternative Names
CRLF3; cytokine receptor-like factor 3; CREME9; CYTOR4; cytokine receptor-like molecule 9; cytokine receptor related protein 4; cytokine receptor-related protein 4; type I cytokine receptor like factor; type I cytokine receptor-like factor p48; FRWS; p48.
CRLF3 (Cytokine receptor-like factor 3) contains one fibronectin type-III domain. It is expressed in skin and squamous cell carcinoma (SCC) and in lesion actinic keratosis (AK).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited DPABH-10318 in a publication? Let us know and earn a reward for your research.
Piao, SG; Choi, MJ; et al. Transforming Growth Factor (TGF)-beta Type I Receptor Kinase (ALK5) Inhibitor Alleviates Profibrotic TGF-beta 1 Responses in Fibroblasts Derived from Peyronie's Plaque. JOURNAL OF SEXUAL MEDICINE 7:3385-3395(2010).
SETO, MH; HARKINS, RN; et al. HOMOLOGY MODEL OF HUMAN INTERFERON-ALPHA-8 AND ITS RECEPTOR COMPLEX. PROTEIN SCIENCE 4:655-670(1995).
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Anti-CRLF3 polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.